SuplatastTosilate CAS:94055-76-2
Suplatast Tosilate is utilized in the management of various allergic conditions, including bronchial asthma, atopic dermatitis, and allergic rhinitis. By modulating the immune response and inhibiting the release of inflammatory mediators, this medication helps to alleviate symptoms such as wheezing, coughing, shortness of breath, itching, and skin rashes associated with these allergic conditions. It is often prescribed when other conventional treatments have been ineffective or poorly tolerated. However, it is essential to use Suplatast Tosilate under the guidance of a healthcare professional, as it may cause side effects such as gastrointestinal disturbances and liver enzyme abnormalities. Patients should follow their healthcare provider's instructions carefully and report any unusual symptoms while taking this medication. Consulting a healthcare provider before initiating or discontinuing Suplatast Tosilate is crucial to ensure safe and appropriate use.
Composition | C23H33NO7S2 |
Assay | 99% |
Appearance | white powder |
CAS No. | 94055-76-2 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |